Investors

Annual Reports

Presentations

BerGenBio regularly presents clinical and pre-clinical data at leading scientific congresses and shares company updates at investor relation conferences. Below are presentations given by the company’s senior management and clinical collaborators.



Q2 2024 Report

Q1 2024 Report

Supplemental prospectus 19 February 2024

Annual Report 2023

Q4 2023 Report

Prospectus 7 December 2023

Q3 2023 Report

Q2 2023 Report

Q1 2023 Report

Prospectus Rights issue 2023

Annual Report 2022

Q4 2022 Report

Q3 2022 Report

Q2 2022 Report

Q1 2022 Report

Annual Report 2021

Q4 and FY 2021 Report

Q3 2021 Report

Q2 2021 Report

Q1 2021 Report

Annual Report 2020

Q4 and FY 2020 Report

Q3 2020 Report

Q2 2020 Report

Prospectus 19 June 2020 BGBIO

Q1 2020 Report

Prospectus 26 February 2020 BGBIO

Annual Report 2019

Q4 and FY 2019 Report

Q3 2019 Report

Q2 2019 Report

Q1 2019 Report

Annual Report 2018

Q4 and FY 2018 Report

Q3 2018 Report

Q2 2018 Report

Q1 2018 Report

Prospectus regarding listing of shares under the Share Option Programme

Q4 and FY 2017 Report

Q3 2017 Report

Q2 2017 Report

Q1 2017 Report

Annual Report 2017

IPO prospectus

Annual Report 2016

Annual Report 2015